Health care stocks were steady pre-bell Friday as the iShares Biotechnology ETF (IBB) and Health Care Select Sector SPDR Fund (XLV) were inactive recently.
CVS Health (CVS) shares fell by over 7% after the company said it expects Q3 adjusted earnings per share of $1.05 to $1.10, including charges to record premium deficiency reserves of around $1.1 billion that lowered its Q3 adjusted EPS by $0.63.
Orgenesis (ORGS) shares tumbled by over 33% after the company said in a regulatory filing that Nasdaq decided to delist the company's shares as it was not in compliance with listing requirements and trading will be suspended on Monday.
Bright Minds Biosciences (DRUG) shares surged past 64% after the company launched a private placement of common shares at a price of $21.70 per share.
Comments